Metabolic engineering of Streptomyces roseosporus for increased production of clinically important antibiotic daptomycin
Abstract Daptomycin (DAP), a novel cyclic lipopeptide antibiotic produced by Streptomyces roseosporus, is clinically important for treatment of infections caused by multidrug‐resistant Gram‐positive pathogens, but the low yield hampers its large‐scale industrial production. Here, we describe a combi...
Saved in:
| Main Authors: | Xingwang Li, Ziwei Sang, Xuejin Zhao, Ying Wen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-11-01
|
| Series: | Microbial Biotechnology |
| Online Access: | https://doi.org/10.1111/1751-7915.70038 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Transcriptional Regulator DhyR Positively Modulates Daptomycin Biosynthesis in Streptomyces roseosporus
by: Fuqiang He, et al.
Published: (2025-03-01) -
Stepwise increase of fidaxomicin in an engineered heterologous host Streptomyces albus through multi-level metabolic engineering
by: Huang Xie, et al.
Published: (2024-12-01) -
Antibiotic Combinations Preventing Bacterial Resistance: Studies on an in vitro Model with Staphylococcus aureus Exposed to Linezolid–Daptomycin
by: K. N. Alieva, et al.
Published: (2020-05-01) -
Antibiotic Combinations Preventing Bacterial Resistance: Studies on an in vitro Model with Staphylococcus aureus Exposed to Linezolid–Daptomycin
by: K. N. Alieva, et al.
Published: (2020-05-01) -
Activity of Carbohydrate Metabolism Enzymes in Streptomyces imbricatus, Producing Imbricin in Controlled Biosynthesis of the Antibiotic
by: O. V. Topkova, et al.
Published: (2020-05-01)